Per Chilstrom

Per Chilstrom

Partner
Baker & McKenzie LLP

Biography

Per Chilstrom is a partner in the Firm’s Transactional Practice Group, based in the New York office. For over 20 years, Per has represented issuers and underwriters on US and cross-border debt and equity offerings including on initial public offerings and follow-on equity offerings, as well as public and private high-yield debt and convertible bond offerings. He has experience across the technology, healthcare and life sciences, insurance, finance, consumer products, energy, and real estate industries. Per also counsels public companies on corporate governance and compliance matters.

Prior to joining Baker McKenzie, Per was a partner at a premier law firm for tech and life sciences companies and formerly a partner in the capital markets group of a leading global law firm.

Practice Focus

Per focuses on capital markets and strategic mergers and acquisitions. He represents clients on de-SPAC mergers and has served as underwriter’s counsel to investment banks on IPOs and follow-on offerings. Per has extensive experience working with non-US companies on debt and equity capital-raising transactions in the United States and has advised underwriters on billions of dollars of cross-border debt and equity offerings across multiple sectors.

Representative Legal Matters

Prior to joining Baker McKenzie, Per advised on the following matters:

  • Molekule, an air purifier company, on its merger with AeroClean Technologies.
  • GeneDx (formerly Sema4), a genomic and clinical data intelligence company, on its USD 150 million common stock offering, its acquisition of Legacy GeneDx and its de-SPAC transaction with CM Life Sciences.
  • Velo3D, a technology company focused on additive manufacturing for high-value metal parts, on its USD 70 million senior secured convertible note offering and its de-SPAC transaction with JAWS Spitfire Acquisition.
  • BILL on its USD 1.4 billion offering of convertible senior notes offering and on its concurrent USD 1.38 billion common stock and USD 575 million convertible senior notes offerings.
  • Proterra, an innovator in commercial vehicle electrification technology, on its de-SPAC transaction with ArcLight Clean Transition.
  • Materialise, a Belgian technology company specializing in 3D printing, on its USD 110 million IPO and on multiple follow-on offerings of ADSs.
  • Quotient, a Jersey, Channel Islands transfusion diagnostics company, on its USD 40 million IPO and on multiple follow-on offerings of ordinary shares and senior secured notes.
  • The underwriters on USD 138 million IPO of Tandem Diabetes Care, a medical device company, and on multiple follow-on offerings of common stock and senior convertible notes.
  • Watford Holdings, a Bermuda based insurance company, on its USD 175 million offering of senior notes and the direct listing of its common shares (the first ever direct listing on the Nasdaq).
  • The underwriters on the USD 125 million offering of junior subordinated notes and on the USD 330 million offering of senior notes of Fidelis Insurance Holdings, a Bermuda-based multi-line insurer and reinsurer.
  • Independence Holding Company, a life and health insurance company, on USD 67 million of issuer tender offers for shares of its common stock and on its going private transaction in respect of its subsidiary, American Independence Company.
  • Petroperu, a Peruvian state-owned petroleum company, on its USD 1.0 billion offering of senior notes and on its USD 2.0 billion offering of senior notes.

Admissions

  • New York~United States (2001)

Education

  • Georgetown University (JD) (2000)
  • Princeton University (AB) (1997)

Languages

  • English